Yttrium Y-90 Epratuzumab Tetraxetan

Preferred Label : Yttrium Y-90 Epratuzumab Tetraxetan;

NCIt synonyms : Y 90 Humanized Monoclonal Antibody LL2; Y90 Humanized Epratuzumab Tetraxetan; Y 90 monoclonal antibody LL2; Yttrium Y 90 Humanized Epratuzumab Tetraxetan; yttrium Y 90 MOAB LL2; Y 90 MoAb LL2; Monoclonal antibody LL2, yttrium Y 90; Yttrium Y 90 Humanized Monoclonal Antibody LL2;

NCIt definition : A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD22, delivering a cytotoxic dose of beta radiation.;

UNII : J36232195E;

CAS number : 501423-25-2;

Chemical formula : C16H25N5O7.Y;

Details

Origin ID

C2582;

UMLS CUI

C0879352;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- B-Cell Receptor CD22 [NCIt concept]
is_component_of_chemotherapy_regimen
- Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients